Home | Symbol Index | About |
(BDOG) > Trackbacks
Thu, 5 Oct 2006 4:00:00 PDT
SARASOTA, FL (MARKET WIRE) DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that two products being developed by Biofrontera AG, a company in Germany in which DNAPrint Genomics owns an 18.3% stake, have been approved for the next stages of their respective clinical trial processes. The products are Biofrontera's BF-200 ALA treatment for actinic keratosis (precancerous and cancerous skin lesions), its lead product, and BF-derm1,
Trackbacks
A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to DNAPrint Genomics, Inc.: DNAPrint Genomics Congratulates Biofrontera AG on Successful Clinical Trial Stages for Two Drugs.
- No trackbacks have been detected.
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.